Artivion, Inc. (AORT)
22.31
+0.38
(+1.73%)
USD |
NYSE |
Oct 02, 16:00
22.27
-0.04
(-0.18%)
Pre-Market: 20:00
Artivion Enterprise Value : 1.417B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.417B |
| October 01, 2026 | 1.398B |
| September 30, 2026 | 1.442B |
| September 29, 2026 | 1.444B |
| September 28, 2026 | 1.448B |
| September 25, 2026 | 1.433B |
| September 24, 2026 | 1.452B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.506B |
| September 21, 2026 | 1.481B |
| September 18, 2026 | 1.468B |
| September 17, 2026 | 1.493B |
| September 16, 2026 | 1.549B |
| September 15, 2026 | 1.566B |
| September 14, 2026 | 1.546B |
| September 11, 2026 | 1.552B |
| September 10, 2026 | 1.531B |
| September 09, 2026 | 1.559B |
| September 08, 2026 | 1.554B |
| September 04, 2026 | 1.576B |
| September 03, 2026 | 1.578B |
| September 02, 2026 | 1.613B |
| September 01, 2026 | 1.650B |
| August 31, 2026 | 1.645B |
| August 28, 2026 | 1.634B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.629B |
| August 26, 2026 | 1.655B |
| August 25, 2026 | 1.615B |
| August 24, 2026 | 1.640B |
| August 21, 2026 | 1.698B |
| August 20, 2026 | 1.693B |
| August 19, 2026 | 1.734B |
| August 18, 2026 | 1.738B |
| August 17, 2026 | 1.710B |
| August 14, 2026 | 1.750B |
| August 13, 2026 | 1.714B |
| August 12, 2026 | 1.725B |
| August 11, 2026 | 1.713B |
| August 10, 2026 | 1.612B |
| August 07, 2026 | 1.651B |
| August 06, 2026 | 1.624B |
| August 05, 2026 | 1.605B |
| August 04, 2026 | 1.640B |
| August 03, 2026 | 1.668B |
| July 31, 2026 | 1.637B |
| July 30, 2026 | 1.678B |
| July 29, 2026 | 1.672B |
| July 28, 2026 | 1.646B |
| July 27, 2026 | 1.602B |
| July 24, 2026 | 1.562B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Alphatec Holdings, Inc. | 2.040B |
| Glaukos Corp. | 9.455B |
| TransMedics Group, Inc. | 3.158B |
| Embecta Corp. | 1.604B |
| Abbott Laboratories | 196.37B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.49M |
| Revenue (Quarterly) | 125.76M |
| Total Expenses (Quarterly) | 139.25M |
| EPS Diluted (Quarterly) | -0.278 |
| Gross Profit Margin (Quarterly) | 60.67% |
| Profit Margin (Quarterly) | -10.73% |
| Earnings Yield | -0.30% |
| Operating Earnings Yield | 2.85% |
| Normalized Earnings Yield | 0.9005 |